Synthesis of benzo[d]imidazo[2,1-b]thiazole-chalcone conjugates as microtubule targeting and apoptosis inducing agents. 2018

Faria Sultana, and Srinivasa Reddy Bonam, and V Ganga Reddy, and V Lakshma Nayak, and Ravikumar Akunuri, and Sunitha Rani Routhu, and Abdullah Alarifi, and M Sampath Kumar Halmuthur, and Ahmed Kamal
Medicinal Chemistry and Biotechnology Division, CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad 500007, India.

A series of benzo[d]imidazo[2,1-b]thiazole-chalcone conjugates (5a-aa) were designed, synthesized and evaluated for their cytotoxic potency against a panel of human cancer cell lines like lung (A-549), breast (MDA MB-231), prostrate (DU-145) and colon cancer (HT-29). Preliminary results revealed that some of these conjugates like 5d and 5u exhibited significant antiproliferative effect against human breast cancer (MDA MB-231) with IC50 values of 1.3 and 1.2 µM respectively. To investigate the mechanistic aspects underlying the activity, the detailed biological studies of these promising conjugates (5d and 5u) were carried out on the MDA MB-231 cancer cells. Flow cytometric analysis revealed that these conjugates induce cell-cycle arrest in the G2/M phase. The tubulin polymerization assay suggests that these conjugates effectively inhibit microtubule assembly. In addition, morphological changes, reactive oxygen species (ROS) detection by 2', 7'-dichlorofluorescin diacetate (DCFDA) and annexin V-FITC/PI assays indicate that 5d and 5u induces apoptosis. Furthermore, in silico computational studies, including molecular docking studies have been carried out to rationalise the binding modes of these conjugates with the tubulin protein.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014404 Tubulin A microtubule subunit protein found in large quantities in mammalian brain. It has also been isolated from SPERM FLAGELLUM; CILIA; and other sources. Structurally, the protein is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to COLCHICINE; VINCRISTINE; and VINBLASTINE. alpha-Tubulin,beta-Tubulin,delta-Tubulin,epsilon-Tubulin,gamma-Tubulin,alpha Tubulin,beta Tubulin,delta Tubulin,epsilon Tubulin,gamma Tubulin
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis

Related Publications

Faria Sultana, and Srinivasa Reddy Bonam, and V Ganga Reddy, and V Lakshma Nayak, and Ravikumar Akunuri, and Sunitha Rani Routhu, and Abdullah Alarifi, and M Sampath Kumar Halmuthur, and Ahmed Kamal
December 2014, ChemMedChem,
Faria Sultana, and Srinivasa Reddy Bonam, and V Ganga Reddy, and V Lakshma Nayak, and Ravikumar Akunuri, and Sunitha Rani Routhu, and Abdullah Alarifi, and M Sampath Kumar Halmuthur, and Ahmed Kamal
January 2019, Anti-cancer agents in medicinal chemistry,
Faria Sultana, and Srinivasa Reddy Bonam, and V Ganga Reddy, and V Lakshma Nayak, and Ravikumar Akunuri, and Sunitha Rani Routhu, and Abdullah Alarifi, and M Sampath Kumar Halmuthur, and Ahmed Kamal
April 2018, Bioorganic chemistry,
Faria Sultana, and Srinivasa Reddy Bonam, and V Ganga Reddy, and V Lakshma Nayak, and Ravikumar Akunuri, and Sunitha Rani Routhu, and Abdullah Alarifi, and M Sampath Kumar Halmuthur, and Ahmed Kamal
August 2022, RSC advances,
Faria Sultana, and Srinivasa Reddy Bonam, and V Ganga Reddy, and V Lakshma Nayak, and Ravikumar Akunuri, and Sunitha Rani Routhu, and Abdullah Alarifi, and M Sampath Kumar Halmuthur, and Ahmed Kamal
January 2017, European journal of medicinal chemistry,
Faria Sultana, and Srinivasa Reddy Bonam, and V Ganga Reddy, and V Lakshma Nayak, and Ravikumar Akunuri, and Sunitha Rani Routhu, and Abdullah Alarifi, and M Sampath Kumar Halmuthur, and Ahmed Kamal
July 2017, Bioorganic & medicinal chemistry,
Faria Sultana, and Srinivasa Reddy Bonam, and V Ganga Reddy, and V Lakshma Nayak, and Ravikumar Akunuri, and Sunitha Rani Routhu, and Abdullah Alarifi, and M Sampath Kumar Halmuthur, and Ahmed Kamal
March 2016, Bioorganic & medicinal chemistry,
Faria Sultana, and Srinivasa Reddy Bonam, and V Ganga Reddy, and V Lakshma Nayak, and Ravikumar Akunuri, and Sunitha Rani Routhu, and Abdullah Alarifi, and M Sampath Kumar Halmuthur, and Ahmed Kamal
January 2022, Medicinal chemistry (Shariqah (United Arab Emirates)),
Faria Sultana, and Srinivasa Reddy Bonam, and V Ganga Reddy, and V Lakshma Nayak, and Ravikumar Akunuri, and Sunitha Rani Routhu, and Abdullah Alarifi, and M Sampath Kumar Halmuthur, and Ahmed Kamal
February 2010, European journal of medicinal chemistry,
Faria Sultana, and Srinivasa Reddy Bonam, and V Ganga Reddy, and V Lakshma Nayak, and Ravikumar Akunuri, and Sunitha Rani Routhu, and Abdullah Alarifi, and M Sampath Kumar Halmuthur, and Ahmed Kamal
October 2020, RSC medicinal chemistry,
Copied contents to your clipboard!